Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




False-Positive Mammogram Findings Tied to Apprehension, Willingness for Future Screening

By MedImaging International staff writers
Posted on 27 Apr 2014
New research has shown that mammograms with false-positive findings were linked with increased short-term anxiety for women, and more women with false-positive results reported that they were more apt to undergo future breast cancer screening.

A percentage of women who undergo routine mammogram screening will experience false-positive findings that necessitate further evaluation to rule out breast cancer.

The authors, Anna N.A. Tosteson, ScD, from the Dartmouth Institute for Health Policy and Clinical Practice (Lebanon, NH, USA), and colleagues reported quality-of-life (QoL) results from the Digital Mammographic Imaging Screening Trial (DMIST). The telephone survey was performed shortly after screening at 22 sites and 1,226 randomly selected women with positive and negative mammogram results were enrolled. Follow-up interviews were obtained from 1,028 of the women (534 with negative results, 494 with false-positive results).

Among women with a false-positive mammogram, 50.6% reported anxiety as moderate or higher and as extreme by 4.6%. However, that did not affect plans by women to undergo screening within the next two years. More women with false-positive results (25.7%) compared with women with negative findings (14.2%) reported that they were “more likely” to undergo future breast cancer screening.

“Our finding of time-limited harm after false-positive screening mammograms is relevant for clinicians who counsel women on mammographic screening and for screening guideline development groups,” the researchers noted.

Related Links:

Dartmouth Institute for Health Policy and Clinical Practice
Digital Mammographic Imaging Screening Trial


Half Apron
Demi
Digital Radiographic System
OMNERA 300M
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Pocket Fetal Doppler
CONTEC10C/CL

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.